These findings are reminiscent of the heterogeneity of symptoms in TauP301 patients, where the initial site of Tau seeding by environmental, genetic or accidental factors, may determine the symptomatic outcome (cognitive symptoms or Parkinsonism). This evidence concerns the gene MAPT and Parkinsonism.